Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

British Journal of Cancer
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. british journal of cancer
  3. regular article
  4. article
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours
Download PDF
Download PDF
  • Regular Article
  • Open access
  • Published: 25 July 2000

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours

  • A A Jungbluth1,
  • E Stockert1,
  • Y-T Chen2,
  • D Kolb1,
  • K Iversen1,
  • K Coplan1,
  • B Williamson1,
  • N Altorki3,
  • K J Busam4 &
  • …
  • L J Old1 

British Journal of Cancer volume 83, pages 493–497 (2000)Cite this article

  • 1604 Accesses

  • 118 Citations

  • Metrics details

This article has been updated

Abstract

Cancer/testis (CT) antigens such as those encoded by the MAGE-gene family are expressed in a wide variety of malignant neoplasms. In normal tissues, expression is generally restricted to testis. Current knowledge of the expression pattern of CT antigens is mainly based on mRNA analysis. Little is known about actual protein expression. We previously developed MA454, a monoclonal antibody (mAb) to MAGE-1 recombinant protein. By employing antigen retrieval techniques, we show that MA454 is reactive on formalin-fixed paraffin-embedded tissues. Immunohistochemical (IHC) analysis of a normal tissue panel revealed staining solely in germ cells of testes. A series of 59 lung tumours was co-typed for MAGE-1 expression by RT–PCR and by immunohistochemistry with MA454. MA454 was positive in 19/59 cases (32%). MAGE-1 mRNA was found in 17 of the 54 cases (32%) available for RT–PCR. Of the 19 MA454-reactive tumours, 15 showed a highly heterogeneous pattern of expression. The other 4 MA454 positive cases revealed immunoreactivity in >25% of tumour areas. Of the 53 cases typed for both, mRNA and protein expression, 48 co-typed whereas 5 cases were discrepant, a likely consequence of heterogeneous MAGE-1 expression. The predominantly focal expression of MAGE-1 suggests that this antigen might not be sufficient as a sole target for immunotherapeutic approaches. © 2000 Cancer Research Campaign

Similar content being viewed by others

Cancer testis antigen MAGEA3 in serum and serum-derived exosomes serves as a promising biomarker in lung adenocarcinoma

Article Open access 30 March 2024

Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer

Article Open access 12 January 2022

Comprehensive analysis of competitive endogenous RNA associated with immune infiltration in lung adenocarcinoma

Article Open access 26 May 2021

Article PDF

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  • Amar-Costesec A, Godelaine D, Stockert E, Van der Bruggen P, Beaufay H and Chen YT (1994) The tumor protein MAGE-1 is located in the cytosol of human melanoma cells. Biochem Biophys Res Commun 204: 710–715

    Article  CAS  PubMed  Google Scholar 

  • Boon T and Old LJ (1997) Cancer tumor antigens. Curr Opin Immunol 9: 681–683

    Article  CAS  PubMed  Google Scholar 

  • Brasseur F, Marchand M, Vanwijck R, Herin M, Lethe B, Chomez P and Boon T (1992) Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer 52: 839–841

    Article  CAS  PubMed  Google Scholar 

  • Carrel S, Schreyer M, Spagnoli G, Cerottini Jc and Rimoldi D (1996) Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells. Int J Cancer 67: 417–422

    Article  CAS  PubMed  Google Scholar 

  • Chen YT and Old LJ (1998) New paths in human cancer serology. J Exp Med 20: 1163–1167

    Google Scholar 

  • Chen YT, Stockert E, Chen Y, Garin-Chesa P, Rettig WJ, Van der Bruggen P, Boon T and Old LJ (1994) Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc Natl Acad Sci USA 91: 1004–1008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cheville JC and Roche PC (1999) MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors. Mod Pathol 12: 974–978

    CAS  PubMed  Google Scholar 

  • De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, de Smet C, Brasseur F, Van der Bruggen P, Lethé B, Lurquin B, Brasseur R, Chomez P, de Backer O, Cavanee W and Boon T (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360–367

    Article  CAS  PubMed  Google Scholar 

  • De Smet C, de Backer O, Faraoni I, Lurquin C, Brasseur F and Boon T (1996) The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci 93: 7149–7153

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ferlazzo G, Meta M, Mesiti M, Cangemi G, Iemmo R, Quartarone G, Fecarotta E, Semino C, Pietra G and Melioli G (1996) Detection of MAGE-1, -2, and -3 messenger RNA in tissue samples derived from lung and mammary tumors. Ann N Y Acad Sci 784: 448–452

    Article  CAS  PubMed  Google Scholar 

  • Fischer C, Gudat F, Stulz P, Noppen C, Schaefer C, Zajac P, Trutmann M, Kocher T, Zuber M, Harder F, Heberer M and Spagnoli GC (1997) High expression of MAGE-3 protein in squamous-cell lung carcinoma [letter]. Int J Cancer 71: 1119–1121

    Article  CAS  PubMed  Google Scholar 

  • Gudat F, Zuber M, Durmuller U, Kocher T, Schaefer C, Noppen C and Spagnoli G (1996) The tumour-associated antigen MAGE-1 is detectable in formal in-fixed paraffin sections of malignant melanoma. Virchows Arch 429: 77–81

    CAS  PubMed  Google Scholar 

  • Hofbauer GF, Schaefer C, Noppen C, Boni R, Kamarashev J, Nestle FO, Spagnoli GC and Dummer R (1997) MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution. Am J Pathol 151: 1549–1553

    CAS  PubMed  PubMed Central  Google Scholar 

  • Itoh K, Hayashi A, Nakao M, Hoshino T, Seki N and Shichijo S (1996) Human tumor rejection antigens MAGE. J Biochem 119: 385–390

    Article  CAS  PubMed  Google Scholar 

  • Jungbluth AA, Busam KJ, Kolb D, Iversen K, Coplan Chen YT, Spagnoli GC and Old LJ (2000) Expression of MAGE-antigens in normal tissues and cancer. J Exp Med 85: 460–465

    CAS  Google Scholar 

  • Jurk M, Kremmer E, Schwarz U, Forster R and Winnacker E-L (1998) MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus. Int J Cancer 75: 762–766

    Article  CAS  PubMed  Google Scholar 

  • Kocher T, Schultz-Thater E, Gudat F, Schaefer C, Casorati G, Juretic A, Willimann T, Harder F, Heberer M and Spagnoli GC (1995) Identification and intracellular location of MAGE-3 gene product. Cancer Res 55: 2236–2239

    CAS  PubMed  Google Scholar 

  • Lucas S, De Smet C, Arden KC, Viars CS, Lethé B, Lurquin C and Boon T (1998) Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 58: 743–752

    CAS  PubMed  Google Scholar 

  • Lurquin C, de Smet C, Brasseur F, Muscatelli F, Martelange V, de Plaen E, Brasseur R, Monaco AP and Boon T (1997) Two members of the human MAGE-B gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 46: 397–408

    Article  CAS  PubMed  Google Scholar 

  • Rimoldi D, Salvi S, Reed D, Coulie P, Jongeneel VC, De Plaen E, Brasseur F, Rodriguez AM, Boon T and Cerottini JC (1999) cDNA and protein characterization of human MAGE-10. Int J Cancer 82: 901–907

    Article  CAS  PubMed  Google Scholar 

  • Sahin U, Tureci O and Pfreundschuh M (1997) Serological identification of human tumor antigens. Curr Opin Immunol 9: 709–716

    Article  CAS  PubMed  Google Scholar 

  • Sakata M (1996) Expression of MAGE gene family in lung cancers. Kurume Med J 43: 55–61

    Article  CAS  PubMed  Google Scholar 

  • Schultz-Thater E, Juretic A, Dellabona P, Lüscher U, Siegrist W, Harder F, Heberer M, Zuber M and Spagnoli GC (1994) MAGE-1 gene product is a cytoplasmic protein. Int J Cancer 59: 435–439

    Article  CAS  PubMed  Google Scholar 

  • Shi SR, Cote RJ and Taylor CR (1996) Antigen retrieval immunohistochemistry: past, present, and future. Appl Immunohistochem 4: 144–166

    Google Scholar 

  • Takahashi K, Shichijo S, Noguchi M, Hirohata M and Itoh K (1995) Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 55: 3478–3482

    CAS  PubMed  Google Scholar 

  • Traversari C, van der Bruggen P, Van den Eynde B, Hainaut P, Lemoine C, Ohta N, Old L and Boon T (1992) Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 35: 145–152

    Article  CAS  PubMed  Google Scholar 

  • Van den Eynde BJ and Boon T (1997) Tumor antigens recognized by T lymphocytes. Int J Clin Lab Res 27: 81–86

    Article  CAS  PubMed  Google Scholar 

  • Van den Eynde BJ and Van der Bruggen P (1997) T cell defined tumor antigens. Curr Opin Immunol 9: 684–693

    Article  CAS  PubMed  Google Scholar 

  • Van der Bruggen P, Traversari C, Chomez P, Lurquin C, de Plaen E, Van den Eynde B, Knuth A and Boon T (1991) A gene encoding an antigen recognized by cytolytic T-lymphocytes on a human melanoma. Science 254: 1643–1646

    Article  CAS  PubMed  Google Scholar 

  • Weynants P, Lethé B, Brasseur F, Marchand M and Boon T (1994) Expression of MAGE genes by non-small-cell lung carcinomas. Int J Cancer 56: 826–829

    Article  CAS  PubMed  Google Scholar 

  • Zuber M, Spagnoli GC, Kocher T, Luscher U, Schaefer C, Noppen C, Gudat F, Harder F and Heberer M (1997) Heterogeneity of melanoma antigen-1 (MAGE-1) gene and protein expression in malignant melanoma. Eur Surg Res 29: 403–410

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ludwig Institute for Cancer Research at Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, 10021, NY, USA

    A A Jungbluth, E Stockert, D Kolb, K Iversen, K Coplan, B Williamson & L J Old

  2. Department of Pathology, New York Presbyterian Hospital-Weill Cornell Medical Center, 1300 York Avenue, New York, 10021, NY, USA

    Y-T Chen

  3. Department of Thoracic Surgery, New York Presbyterian Hospital-Weill Cornell Medical Center, 1300 York Avenue, New York, 10021, NY, USA

    N Altorki

  4. Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, 10021, NY, USA

    K J Busam

Authors
  1. A A Jungbluth
    View author publications

    Search author on:PubMed Google Scholar

  2. E Stockert
    View author publications

    Search author on:PubMed Google Scholar

  3. Y-T Chen
    View author publications

    Search author on:PubMed Google Scholar

  4. D Kolb
    View author publications

    Search author on:PubMed Google Scholar

  5. K Iversen
    View author publications

    Search author on:PubMed Google Scholar

  6. K Coplan
    View author publications

    Search author on:PubMed Google Scholar

  7. B Williamson
    View author publications

    Search author on:PubMed Google Scholar

  8. N Altorki
    View author publications

    Search author on:PubMed Google Scholar

  9. K J Busam
    View author publications

    Search author on:PubMed Google Scholar

  10. L J Old
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and permissions

About this article

Cite this article

Jungbluth, A., Stockert, E., Chen, YT. et al. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer 83, 493–497 (2000). https://doi.org/10.1054/bjoc.2000.1291

Download citation

  • Received: 30 November 1999

  • Revised: 07 March 2000

  • Accepted: 07 March 2000

  • Published: 25 July 2000

  • Issue date: 01 August 2000

  • DOI: https://doi.org/10.1054/bjoc.2000.1291

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • MAGE-1 antigen
  • monoclonal antibody MA454

This article is cited by

  • Expression von Cancer-Testis(CT)-Antigenen in Melanomen des Kindes- und Jugendalters

    • N. Behrendt
    • T. Schultewolter
    • A. Jungbluth

    Der Pathologe (2017)

  • Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area

    • K Sideras
    • S J Bots
    • J Kwekkeboom

    British Journal of Cancer (2015)

  • Cancer testis antigen expression in testicular germ cell tumorigenesis

    • Peter K Bode
    • Andrea Thielken
    • Holger Moch

    Modern Pathology (2014)

  • Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications

    • Dimitrios Balafoutas
    • Axel zur Hausen
    • Elmar Stickeler

    BMC Cancer (2013)

  • Cancer-testis antigen expression and immunogenicity in AL amyloidosis

    • M A Rosenzweig
    • H Landau
    • G Koehne

    Blood Cancer Journal (2012)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open access publishing
  • About the Editors
  • Contact
  • Special Issues
  • For Advertisers
  • Subscribe

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

British Journal of Cancer (Br J Cancer)

ISSN 1532-1827 (online)

ISSN 0007-0920 (print)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited